Have a personal or library account? Click to login
µ-Crystallin: A thyroid hormone binding protein Cover

µ-Crystallin: A thyroid hormone binding protein

Open Access
|May 2021

References

  1. Abdalla SM, Bianco AC. Defending plasma T3 is a biological priority. Clin Endocrinol (Oxf) 81, 633–641, 2014.10.1111/cen.12538
  2. Abe S, Katagiri T, Saito-Hisaminato A, Usami S, Inoue Y, Tsunoda T, Nakamura Y. Identification of CRYM as a candidate responsible for nonsyndromic deafness, through cDNA microarray analysis of human cochlear and vestibular tissues. Am J Hum Genet 72, 73–82, 2003.10.1086/345398
  3. Ahmed JN, Diamand KEM, Bellchambers HM, Arkell RM. Systematized reporter assays reveal ZIC protein regulatory abilities are Subclass-specific and dependent upon transcription factor binding site context. Sci Rep 10, 13130, 2020.10.1038/s41598-020-69917-9
  4. Apriletti JW, Ribeiro RC, Wagner RL, Feng W, Webb P, Kushner PJ, West BL, Nilsson S, Scanlan TS, Fletterick RJ, Baxter JD. Molecular and structural biology of thyroid hormone receptors. Clin Exp Pharmacol Physiol Suppl 25, S2–S11, 1998.10.1111/j.1440-1681.1998.tb02293.x
  5. Arion D, Unger T, Lewis DA, Levitt P, Mirnics K. Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry 62, 711–721, 2007.10.1016/j.biopsych.2006.12.021
  6. Arlotta P, Molyneaux BJ, Chen J, Inoue J, Kominami R, Macklis JD. Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo. Neuron 45, 207–221, 2005.10.1016/j.neuron.2004.12.036
  7. Beasley CL, Pennington K, Behan A, Wait R, Dunn MJ, Cotter D. Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for disease-associated changes. Proteomics 6, 3414–3425, 2006.10.1002/pmic.200500069
  8. Beckett GJ, Arthur JR. 3 The iodothyronine deiodinases and 5’-deiodination. Baillière’s clinical endocrinology and metabolism 8, 285–304, 1994.10.1016/S0950-351X(05)80253-8
  9. Bello F, and Bakari A. Hypothyroidism in adults: A review and recent advances in management. J Diabetes Endocrinol 3, 57–69, 2012.10.5897/JDE11.017
  10. Beslin A, Vie MP, Blondeau JP, Francon J. Identification by photoaffinity labelling of a pyridine nucleotide-dependent tri-iodothyronine-binding protein in the cytosol of cultured astroglial cells. Biochem J 305, 729–737, 1995.10.1042/bj305072911363207848271
  11. Beziat V, Li J, Lin JX, Ma CS, Li P, Bousfiha A, et al. A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity. Sci Immunol 3, eaat4956, 2018.
  12. Borel F, Hachi I, Palencia A, Gaillard MC, Ferrer JL. Crystal structure of mouse mu-crystallin complexed with NADPH and the T3 thyroid hormone. FEBS J 281, 1598–1612, 2014.10.1111/febs.1272624467707
  13. Brent GA. Mechanisms of thyroid hormone action. J Clin Invest 122, 3035–3043, 2012.10.1172/JCI60047343395622945636
  14. Brochier C, Gaillard MC, Diguet E, Caudy N, Dossat C, Segurens B, Wincker P, Roze E, Caboche J, Hantraye P, Brouillet E, Elalouf JM, de Chaldee M. Quantitative gene expression profiling of mouse brain regions reveals differential transcripts conserved in human and affected in disease models. Physiol Genomics 33, 170–179, 2008.10.1152/physiolgenomics.00125.200718252803
  15. Casas F, Rochard P, Rodier A, Cassar-Malek I, Marchal-Victorion S, Wiesner RJ, Cabello G, Wrutniak C. A variant form of the nuclear triiodothyronine receptor c-ErbAα1 plays a direct role in regulation of mitochondrial RNA synthesis. Mol Cell Biol 19, 7913–7924, 1999.10.1128/MCB.19.12.79138487610567517
  16. Casas F, Busson M, Grandemange S, Seyer P, Carazo A, Pessemesse L, Wrutniak-Cabello C, Cabello G. Characterization of a novel thyroid hormone receptor α variant involved in the regulation of myoblast differentiation. Mol Endocrinol 20, 749–763, 2006.10.1210/me.2005-007416322094
  17. Chassande O, Fraichard A, Gauthier K, Flamant F, Legrand C, Savatier P, Laudet V, Samarut J. Identification of transcripts initiated from an internal promoter in the c-erbA alpha locus that encode inhibitors of retinoic acid receptor-alpha and triiodothyronine receptor activities. Mol Endocrinol 11, 1278–1290, 1997.10.1210/mend.11.9.99729259319
  18. Chopra IJ. A study of extrathyroidal conversion of thyroxine (T4) to 3, 3’, 5-triiodothyronine (T3) in vitro. Endocrinology 101, 453–463, 1977.10.1210/endo-101-2-45318337
  19. Close R. Force: velocity properties of mouse muscles. Nature 206, 718–719, 1965.10.1038/206718a05832859
  20. Daoud H, Valdmanis PN, Gros-Louis F, Belzil V, Spiegelman D, Henrion E, Diallo O, Desjarlais A, Gauthier J, Camu W, Dion PA, Rouleau GA. Resequencing of 29 candidate genes in patients with familial and sporadic amyotrophic lateral sclerosis. Arch Neuro 68, 587–593, 2011.10.1001/archneurol.2010.35121220648
  21. Deme D, Fimiani E, Pommier J, Nunez J. Free diiodotyrosine effects on protein iodination and thyroid hormone synthesis catalyzed by thyroid peroxidase. Eur J Biochem 51, 329–336, 1975.10.1111/j.1432-1033.1975.tb03932.x1149735
  22. Ducros G, Trippenbach T. Respiratory effects of lactic acid injected into the jugular vein of newborn rabbits. Pediatr Res 29, 548–552, 1991.10.1203/00006450-199106010-000061866210
  23. Eckey M, Moehren U, Baniahmad A. Gene silencing by the thyroid hormone receptor. Mol Cell Endocrinol 213, 13–22, 2003.10.1016/j.mce.2003.10.02615062570
  24. Fekete C, Mihaly E, Luo LG, Kelly J, Clausen JT, Mao Q, Rand WM, Moss LG, Kuhar M, Emerson CH, Jackson IM, Lechan RM. Association of cocaine- and amphetamine-regulated transcript-immunoreactive elements with thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and its role in the regulation of the hypothalamic-pituitary-thyroid axis during fasting. J Neurosci 20, 9224–9234, 2000.10.1523/JNEUROSCI.20-24-09224.2000
  25. Fekete C, Kelly J, Mihaly E, Sarkar S, Rand WM, Legradi G, Emerson CH, Lechan RM. Neuropeptide Y has a central inhibitory action on the hypothalamic-pituitary-thyroid axis. Endocrinology 142, 2606–2613, 2001.10.1210/endo.142.6.820711356711
  26. Fekete C, Sarkar S, Rand WM, Harney JW, Emerson CH, Bianco AC, Lechan RM. Agouti-related protein (AGRP) has a central inhibitory action on the hypothalamic-pituitary-thyroid (HPT) axis; comparisons between the effect of AGRP and neuropeptide Y on energy homeostasis and the HPT axis. Endocrinology 143, 3846–3853, 2002.10.1210/en.2002-22033812239096
  27. Fekete C, Lechan RM. Negative feedback regulation of hypophysiotropic thyrotropin-releasing hormone (TRH) synthesizing neurons: role of neuronal afferents and type 2 deiodinase. Front Neuroendocrinol 28, 97–114, 2007.10.1016/j.yfrne.2007.04.002200045517588648
  28. Figueroa-Romero C, Hur J, Lunn JS, Paez-Colasante X, Bender DE, Yung R, Sakowski SA, Feldman EL. Expression of microRNAs in human post-mortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanisms. Mol Cell Neurosci 71, 34–45, 2016.10.1016/j.mcn.2015.12.008476149826704906
  29. Fink KL, Strittmatter SM, Cafferty WB. Comprehensive Corticospinal Labeling with mu-crystallin Transgene Reveals Axon Regeneration after Spinal Cord Trauma in ngr1-/- Mice. J Neurosci 35, 15403–15418, 2015.10.1523/JNEUROSCI.3165-15.2015464901026586827
  30. Fitts RH, Brimmer CJ, Troup JP, Unsworth BR. Contractile and fatigue properties of thyrotoxic rat skeletal muscle. Muscle Nerve 7, 470–477, 1984.10.1002/mus.8800706096543899
  31. Fornes O, Castro-Mondragon JA, Khan A, van der Lee R, Zhang X, Richmond PA, Modi BP, Correard S, Gheorghe M, Baranasic D, Santana-Garcia W, Tan G, Cheneby J, Ballester B, Parcy F, Sandelin A, Lenhard B, Wasserman WW, Mathelier A. JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res 48, D87–D92, 2020.10.1093/nar/gkz1001714562731701148
  32. Francelle L, Galvan L, Gaillard MC, Guillermier M, Houitte D, Bonvento G, Petit F, Jan C, Dufour N, Hantraye P, Elalouf JM, De Chaldee M, Deglon N, Brouillet E. Loss of the thyroid hormone-binding protein Crym renders striatal neurons more vulnerable to mutant huntingtin in Huntington’s disease. Hum Mol Genet 24, 1563–1573, 2015.10.1093/hmg/ddu571
  33. Freake HC, Oppenheimer JH. Thermogenesis and thyroid function. Annu Rev Nutr 15, 263–291, 1995.10.1146/annurev.nu.15.070195.001403
  34. Frey-Jakobs S, Hartberger JM, Fliegauf M, Bossen C, Wehmeyer ML, Neubauer JC, Bulashevska A, Proietti M, Frobel P, Noltner C, Yang L, Rojas-Restrepo J, Langer N, Winzer S, Engelhardt KR, Glocker C, Pfeifer D, Klein A, Schaffer AA, Lagovsky I, Lachover-Roth I, Beziat V, Puel A, Casanova JL, Fleckenstein B, Weidinger S, Kilic SS, Garty BZ, Etzioni A, Grimbacher B. ZNF341 controls STAT3 expression and thereby immunocompetence. Sci Immunol 3, eaat4941, 2018.10.1126/sciimmunol.aat4941
  35. Friesema EC, Docter R, Moerings EP, Stieger B, Hagenbuch B, Meier PJ, Krenning EP, Hennemann G, Visser TJ. Identification of thyroid hormone transporters. Biochem Biophys Res Commun 254, 497–501, 1999.10.1006/bbrc.1998.9974
  36. Fukada Y, Yasui K, Kitayama M, Doi K, Nakano T, Watanabe Y, Nakashima K. Gene expression analysis of the murine model of amyotrophic lateral sclerosis: studies of the Leu126delTT mutation in SOD1. Brain Res 1160, 1–10, 2007.10.1016/j.brainres.2007.05.044
  37. Gallagher DT, Monbouquette HG, Schroder I, Robinson H, Holden MJ, Smith NN. Structure of alanine dehydrogenase from Archaeoglobus: active site analysis and relation to bacterial cyclodeaminases and mammalian mu crystallin. J Mol Biol 342, 119–130, 2004.10.1016/j.jmb.2004.06.090
  38. Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol 196, 261–282, 1987.10.1016/0022-2836(87)90689-9
  39. Graupner G, Wills KN, Tzukerman M, Zhang XK, Pfahl M. Dual regulatory role for thyroid-hormone receptors allows control of retinoic-acid receptor activity. Nature 340, 653–656, 1989.10.1038/340653a02549424
  40. GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat Genet 45, 580–585, 2013.
  41. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A 98, 4746–4751, 2001.10.1073/pnas.0810711983190511296301
  42. Hallen A, Cooper AJ, Jamie JF, Haynes PA, Willows RD. Mammalian forebrain ketimine reductase identified as μ-crystallin; potential regulation by thyroid hormones. J Neurochem 118, 379–387, 2011.10.1111/j.1471-4159.2011.07220.x21332720
  43. Hallen A, Cooper AJ, Jamie JF, Karuso P. Insights into Enzyme Catalysis and Thyroid Hormone Regulation of Cerebral Ketimine Reductase/μ-Crystallin Under Physiological Conditions. Neurochem Res 40, 1252–1266, 2015a.10.1007/s11064-015-1590-5
  44. Hallen A, Cooper AJ, Smith JR, Jamie JF, Karuso P. Ketimine reductase/CRYM catalyzes reductive alkylamination of α-keto acids, confirming its function as an imine reductase. Amino Acids 47, 2457–2461, 2015b.10.1007/s00726-015-2044-8
  45. Hallen A, Cooper AJ. Reciprocal Control of Thyroid Binding and the Pipecolate Pathway in the Brain. Neurochem Res 42, 217–243, 2017.10.1007/s11064-016-2015-9
  46. Harris M, Aschkenasi C, Elias CF, Chandrankunnel A, Nillni EA, Bjøorbaek C, Elmquist JK, Flier JS, Hollenberg AN. Transcriptional regulation of the thyrotropin-releasing hormone gene by leptin and melanocortin signaling. J Clin Invest 107, 111–120, 2001.10.1172/JCI10741
  47. Hashizume K, Kobayashi M, Miyamoto T. Active and inactive forms of 3,5,3’-triiodo-L-thyronine (T3)-binding protein in rat kidney cytosol: possible role of nicotinamide adenine dinucleotide phosphate in activation of T3 binding. Endocrinology 19, 710–719, 1986.10.1210/endo-119-2-710
  48. Hashizume K, Miyamoto T, Ichikawa K, Yamauchi K, Kobayashi M, Sakurai A, Ohtsuka H, Nishii Y, Yamada T. Purification and characterization of NADPH-dependent cytosolic 3,5,3’-triiodo-L-thyronine binding protein in rat kidney. J Biol Chem 264, 4857–4863, 1989a.10.1016/S0021-9258(18)83670-5
  49. Hashizume K, Miyamoto T, Kobayashi M, Suzuki S, Ichikawa K, Yamauchi K, Ohtsuka H, Takeda T. Cytosolic 3,5,3’-triiodo-L-thyronine (T3)-binding protein (CTBP) regulation of nuclear T3 binding: evidence for the presence of T3-CTBP complex-binding sites in nuclei. Endocrinology 124, 2851–2856, 1989b.10.1210/endo-124-6-2851
  50. Hashizume K, Miyamoto T, Yamauchi K, Ichikawa K, Kobayashi M, Ohtsuka H, Sakurai A, Suzuki S, Yamada T. Counterregulation of nuclear 3,5,3’-triiodo-L-thyronine (T3) binding by oxidized and reduced-nicotin-amide adenine dinucleotide phosphates in the presence of cytosolic T3-binding protein in vitro. Endocrinology 124, 1678–1683, 1989c.10.1210/endo-124-4-1678
  51. Hashizume K, Miyamoto T, Ichikawa K, Yamauchi K, Sakurai A, Ohtsuka H, Kobayashi M, Nishii Y, Yamada T. Evidence for the presence of two active forms of cytosolic 3,5,3’-triiodo-L-thyronine (T3)-binding protein (CTBP) in rat kidney. Specialized functions of two CTBPs in intracellular T3 translocation. J Biol Chem 264, 4864–4871, 1989d.10.1016/S0021-9258(18)83671-7
  52. Heuer H, Schafer MK, O’Donnell D, Walker P, Bauer K. Expression of thyrotropin-releasing hormone receptor 2 (TRH-R2) in the central nervous system of rats. J Comp Neurol 428, 319–336, 2000.10.1002/1096-9861(20001211)428:2<319::AID-CNE10>3.0.CO;2-9
  53. Hinaux H, Blin M, Fumey J, Legendre L, Heuzé A, Casane D, Rétaux S. Lens defects in Astyanax mexicanus Cavefish: evolution of crystallins and a role for alphaA-crystallin. Dev Neurobiol 75, 505–521, 2015.10.1002/dneu.2223925348293
  54. Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, Hughes G, Elliston LA, Hartog C, Goldstein DR, Thu D, Hollingsworth ZR, Collin F, Synek B, Holmans PA, Young AB, Wexler NS, Delorenzi M, Kooperberg C, Augood SJ, Faull RL, Olson JM, Jones L, Luthi-Carter R. Regional and cellular gene expression changes in human Huntington’s disease brain. Hum Mol Genet 15, 965–977, 2006.10.1093/hmg/ddl01316467349
  55. Hodin RA, Lazar MA, Wintman BI, Darling DS, Koenig RJ, Larsen PR, Moore DD, Chin WW. Identification of a thyroid hormone receptor that is pituitary-specific. Science 244, 76–79, 1989.10.1126/science.25396422539642
  56. Hommyo R, Suzuki SO, Abolhassani N, Hamasaki H, Shijo M, Maeda N, Honda H, Nakabeppu Y, Iwaki T. Expression of CRYM in different rat organs during development and its decreased expression in degenerating pyramidal tracts in amyotrophic lateral sclerosis. Neuropathology 38, 247–259, 2018.10.1111/neup.1246629603402
  57. Imai H, Ohta K, Yoshida A, Suzuki S, Hashizume K, Usami S, Kikuchi T. {mu}-Crystallin, new candidate protein in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci 51, 3554–3559, 2010.10.1167/iovs.09-372820570996
  58. Jansen J, Friesema EC, Milici C, Visser TJ. Thyroid hormone transporters in health and disease. Thyroid 15, 757–768, 2005.10.1089/thy.2005.15.75716131319
  59. Jhanwar SC, Chaganti RS, Croce CM. Germ-line chromosomal localization of human C-Erb-A oncogene. Somat Cell Mol Genet 11, 99–102, 1985.10.1007/BF015347403856334
  60. Johnston-Wilson NL, Sims CD, Hofmann JP, Anderson L, Shore AD, Torrey EF, Yolken RH. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Mol Psychiatry 5, 142–149, 2000.10.1038/sj.mp.400069610822341
  61. Joshi SS, Sethi M, Striz M, Cole N, Denegre JM, Ryan J, Lhamon ME, Agarwal A, Murray S, Braun RE, Fardo DW, Kumar V, Donohue KD, Sunderam S, Chesler EJ, Svenson KL, O’Hara BF. Noninvasive sleep monitoring in large-scale screening of knock-out mice reveals novel sleep-related genes. bioRxiv, 517680, 2019.10.1101/517680
  62. Kalmar B, Blanco G, Greensmith L. Determination of Muscle Fiber Type in Rodents. Curr Protoc Mouse Biol 2, 231–243, 2012.10.1002/9780470942390.mo11022926069013
  63. Kalyanaraman H, Schwappacher R, Joshua J, Zhuang S, Scott BT, Klos M, Casteel DE, Frangos JA, Dillmann W, Boss GR, Pilz RB. Nongenomic thyroid hormone signaling occurs through a plasma membrane-localized receptor. Sci Signal 7, ra48, 2014.10.1126/scisignal.2004911
  64. Kim RY, Gasser R, Wistow GJ. mu-crystallin is a mammalian homologue of Agrobacterium ornithine cyclodeaminase and is expressed in human retina. Proc Natl Acad Sci U S A 89, 9292–9296, 1992.10.1073/pnas.89.19.9292
  65. Kinney CJ, O’Neill A, Noland K, Huang W, Muriel J, Lukyanenko V, Kane MA, Ward CW, Collier AF, Roche JA, McLenithan JC, Reed PW, Bloch RJ. μ-Crystallin in mouse skeletal muscle promotes a shift from glycolytic toward oxidative metabolism. Current Research in Physiology 4, 47–59, 2021.10.1016/j.crphys.2021.02.003
  66. Kobayashi M, Hashizume K, Suzuki S, Ichikawa K, Takeda T. A novel NADPH-dependent cytosolic 3,5,3’-triiodo-L-thyronine-binding protein (CTBP; 5.1S) in rat liver: a comparison with 4.7S NADPH-dependent CTBP. Endocrinology 129, 1701–1708, 1991.10.1210/endo-129-4-1701
  67. Kubota K, Uchimura H, Mitsuhashi T, Chiu SC, Kuzuya N, Nagataki S. Effects of intrathyroidal metabolism of thyroxine on thyroid hormone secretion: increased degradation of thyroxine in mouse thyroids stimulated chronically with thyrotrophin. Acta Endocrinol (Copenh) 105, 57–65, 1984.10.1530/acta.0.1050057
  68. Larsen PR, Silva JE, Kaplan MM. Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications. Endocr Rev 2, 87–102, 1981.10.1210/edrv-2-1-87
  69. Legradi G, Emerson CH, Ahima RS, Flier JS, Lechan RM. Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology138, 2569–2576, 1997.10.1210/endo.138.6.5209
  70. Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 445, 168–176, 2007.
  71. Liu X, Wei S, Deng S, Li D, Liu K, Shan B, Shao Y, Wei W, Chen J, Zhang L. Genome-wide identification and comparison of mRNAs, lncRNAs and circRNAs in porcine intramuscular, subcutaneous, retroperitoneal and mesenteric adipose tissues. Anim Genet 50, 228–241, 2019.10.1111/age.12781
  72. Liu YY, Milanesi A, Brent GA. Thyroid Hormones. In: Hormonal Signaling in Biology and Medicine (Ed. G. Litwack), pp. 487–506, Elsevier, 2020.10.1016/B978-0-12-813814-4.00021-3
  73. Lusk G. Animal calorimetry: twenty-fourth paper. Analysis of the oxidation of mixtures of carbohydrate and fat J Biol Chem 59, 41–42, 1924.10.1016/S0021-9258(18)85293-0
  74. Mansourian AR. A review on hyperthyroidism: thyrotoxicosis under surveillance. Pak J Biol Sci 13, 1066–1076, 2010.10.3923/pjbs.2010.1066.107621313880
  75. Martins-de-Souza D, Gattaz WF, Schmitt A, Rewerts C, Maccarrone G, Dias-Neto E, Turck CW. Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia. Eur Arch Psychiatry Clin Neurosci 259, 151–163, 2009a.10.1007/s00406-008-0847-219165527
  76. Martins-de-Souza D, Gattaz WF, Schmitt A, Maccarrone G, Hunyadi-Gulyás E, Eberlin MN, Souza GH, Marangoni S, Novello JC, Turck CW, Dias-Neto E. Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. J Psychiatr Res 43, 978–986, 2009b.10.1016/j.jpsychires.2008.11.00619110265
  77. Martins-de-Souza D, Maccarrone G, Wobrock T, Zerr I, Gormanns P, Reckow S, Falkai P, Schmitt A, Turck CW. Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential bio-markers candidates for schizophrenia. J Psychiatr Res 44, 1176–1189, 2010.10.1016/j.jpsychires.2010.04.01420471030
  78. Mendoza A, Hollenberg AN. New insights into thyroid hormone action. Pharmacol Ther 173, 135–145, 2017.10.1016/j.pharmthera.2017.02.012540791028174093
  79. Mengeling BJ, Pan F, Privalsky ML. Novel mode of deoxyribonucleic acid recognition by thyroid hormone receptors: thyroid hormone receptor beta-isoforms can bind as trimers to natural response elements comprised of reiterated half-sites. Mol Endocrinol 19, 35–51, 2005.10.1210/me.2003-028915459250
  80. Middleton FA, Mirnics K, Pierri JN, Lewis DA, Levitt P. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci 22, 2718–2729, 2002.10.1523/JNEUROSCI.22-07-02718.2002
  81. Miga KH, Eisenhart C, Kent WJ. Utilizing mapping targets of sequences underrepresented in the reference assembly to reduce false positive alignments. Nucleic Acids Res 43, e133, 2015.10.1093/nar/gkv671478776126163063
  82. Mihaly E, Fekete C, Tatro JB, Liposits Z, Stopa EG, Lechan RM. Hypophysiotropic thyrotropin-releasing hormone-synthesizing neurons in the human hypothalamus are innervated by neuropeptide Y, agouti-related protein, and alpha-melanocyte-stimulating hormone. J Clin Endocrinol Metab 85, 2596–2603, 2000.10.1210/jc.85.7.2596
  83. Miklos GL, Maleszka R. Microarray reality checks in the context of a complex disease. Nat Biotechnol 22, 615–621, 2004.10.1038/nbt96515122300
  84. Mitchell AM, Tom M, Mortimer RH. Thyroid hormone export from cells: contribution of P-glycoprotein. J Endocrinol 185, 93–98, 2005.10.1677/joe.1.06096
  85. Mori J, Suzuki S, Kobayashi M, Inagaki T, Komatsu A, Takeda T, Miyamoto T, Ichikawa K, Hashizume K. Nicotin-amide adenine dinucleotide phosphate-dependent cytosolic T(3) binding protein as a regulator for T(3)-mediated transactivation. Endocrinology 143, 1538–1544, 2002.10.1210/endo.143.4.8736
  86. Morley JE. Extrahypothalamic thyrotropin releasing hormone (TRH) -- its distribution and its functions. Life Sci 25, 1539–1550, 1979.10.1016/0024-3205(79)90435-1
  87. Mukai M, Replogle K, Drnevich J, Wang G, Wacker D, Band M, Clayton DF, Wingfield JC. Seasonal differences of gene expression profiles in song sparrow (Melospiza melodia) hypothalamus in relation to territorial aggression. PLoS One 4, e8182, 2009.10.1371/journal.pone.0008182278071719997634
  88. O’Shea PJ, Williams GR. Insight into the physiological actions of thyroid hormone receptors from genetically modified mice. J Endocrinol 175, 553–570, 2002.10.1677/joe.0.175055312475367
  89. Ohkubo Y, Sekido T, Nishio SI, Sekido K, Kitahara J, Suzuki S, Komatsu M. Loss of μ-crystallin causes PPARγ activation and obesity in high-fat diet-fed mice. Biochem Biophys Res Commun 508, 914–920, 2019.10.1016/j.bbrc.2018.12.03830545633
  90. Ojha A, Watve M. Blind fish: An eye opener. Evol Med Public Health 2018, 186–189, 2018.10.1093/emph/eoy020610509530151194
  91. Oshima A, Suzuki S, Takumi Y, Hashizume K, Abe S, Usami S. CRYM mutations cause deafness through thyroid hormone binding properties in the fibrocytes of the cochlea. J Med Genet 43, e25, 2006.10.1136/jmg.2005.034397256454316740909
  92. Pantos C, Mourouzis I. Thyroid hormone receptor α1 as a novel therapeutic target for tissue repair. Ann Transl Med 6, 254, 2018.10.21037/atm.2018.06.12604629130069456
  93. Pensato V, Magri S, Bella ED, Tannorella P, Bersano E, Sorarù G, Gatti M, Ticozzi N, Taroni F, Lauria G, Mariotti C, Gellera C. Sorting Rare ALS Genetic Variants by Targeted Re-Sequencing Panel in Italian Patients: OPTN, VCP, and SQSTM1 Variants Account for 3% of Rare Genetic Forms. J Clin Med 9, 412, 2020.10.3390/jcm9020412707390132028661
  94. Phan L, Jin Y, Zhang H, Qiang W, Shekhtman E, Shao D, Revoe D, Villamarin R, Ivanchenko E, Kimura M, Wang ZY, Hao L, Sharopova N, Bihan M, Sturcke A, Lee M, Popova N, Wu W, Bastiani C, Ward M, Holmes JB, Lyoshin V, Kaur K, Moyer E, Feolo M, Kattman BL. “ALFA: Allele Frequency Aggregator.” National Center for Biotechnology Information, U.S. National Library of Medicine, 10 Mar. 2020, www.ncbi.nlm.nih.gov/snp/docs/gsr/alfa/.
  95. Pihlajamaki J, Boes T, Kim EY, Dearie F, Kim BW, Schroeder J, Mun E, Nasser I, Park PJ, Bianco AC, Goldfine AB, Patti ME. Thyroid hormone-related regulation of gene expression in human fatty liver. J Clin Endocrinol Metab 94, 3521–3529, 2009.10.1210/jc.2009-0212274171319549744
  96. Pirahanchi Y, Tariq MA, Jialal I. Physiology, Thyroid. [Updated 2021 Feb 9]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519566/.10.1093/database/baab080873028734964845
  97. Raparti G, Jain S, Ramteke K, Murthy M, Ghanghas R, Ramanand S, Ramanand J. Selective thyroid hormone receptor modulators. Indian J Endocrinol Metab 17, 211–218, 2013.10.4103/2230-8210.109663368319323776891
  98. Reed PW, Corse AM, Porter NC, Flanigan KM, Bloch RJ. Abnormal expression of mu-crystallin in facioscapulohumeral muscular dystrophy. Exp Neurol 205, 583–586, 2007.10.1016/j.expneurol.2007.03.00917451686
  99. Rodriguez-Rodriguez A, Lazcano I, Sanchez-Jaramillo E, Uribe RM, Jaimes-Hoy L, Joseph-Bravo P, Charli JL. Tanycytes and the control of thyrotropin-releasing hormone flux into portal capillaries. Front Endocrinol (Lausanne) 10, 401, 2019.10.3389/fendo.2019.00401660309531293518
  100. Saetre P, Lindberg J, Leonard JA, Olsson K, Pettersson U, Ellegren H, Bergstrom TF, Vila C, Jazin E. From wild wolf to domestic dog: gene expression changes in the brain. Brain Res Mol Brain Res 126, 198–206, 2004.10.1016/j.molbrainres.2004.05.00315249144
  101. Samocha KE, Robinson EB, Sanders SJ, Stevens C, Sabo A, McGrath LM, Kosmicki JA, Rehnstrom K, Mallick S, Kirby A, Wall DP, MacArthur DG, Gabriel SB, DePristo M, Purcell SM, Palotie A, Boerwinkle E, Buxbaum JD, Cook EH Jr, Gibbs RA, Schellenberg GD, Sutcliffe JS, Devlin B, Roeder K, Neale BM, Daly MJ. A framework for the interpretation of de novo mutation in human disease. Nat Genet 46, 944–950, 2014.10.1038/ng.3050422218525086666
  102. Sanchez E, Uribe RM, Corkidi G, Zoeller RT, Cisneros M, Zacarias M, Morales-Chapa C, Charli JL, Joseph-Bravo P. Differential responses of thyrotropin-releasing hormone (TRH) neurons to cold exposure or suckling indicate functional heterogeneity of the TRH system in the paraventricular nucleus of the rat hypothalamus. Neuroendocrinology 74, 407–422, 2001.10.1159/00005470711752897
  103. Sandler B, Webb P, Apriletti JW, Huber BR, Togashi M, Cunha Lima ST, Juric S, Nilsson S, Wagner R, Fletterick RJ, Baxter JD. Thyroxine-thyroid hormone receptor interactions. J Biol Chem 279, 55801–55808, 2004.10.1074/jbc.M41012420015466465
  104. Sap J, Munoz A, Damm K, Goldberg Y, Ghysdael J, Leutz A, Beug H, Vennstrom B. The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature 324, 635–640, 1986.10.1038/324635a02879242
  105. Sapp PC, Hosler BA, McKenna-Yasek D, Chin W, Gann A, Genise H, Gorenstein J, Huang M, Sailer W, Scheffler M, Valesky M, Haines JL, Pericak-Vance M, Siddique T, Horvitz HR, Brown RH Jr. Identification of two novel loci for dominantly inherited familial amyotrophic lateral sclerosis. Am J Hum Genet 73, 397–403, 2003.10.1086/377158118037712858291
  106. Schaefer JS, Klein JR. Immunological regulation of metabolism--a novel quintessential role for the immune system in health and disease. FASEB J 25, 29–34, 2011.10.1096/fj.10-168203300543320826543
  107. Schiaffino S, Reggiani C. Fiber types in mammalian skeletal muscles. Physiol Rev 91, 1447–1531, 2011.10.1152/physrev.00031.201022013216
  108. Schimmel M, Utiger RD. Thyroidal and peripheral production of thyroid hormones. Review of recent findings and their clinical implications. Ann Intern Med 87, 760–768, 1977.10.7326/0003-4819-87-6-760412452
  109. Seko D, Ogawa S, Li TS, Taimura A, Ono Y. μ-Crystallin controls muscle function through thyroid hormone action. FASEB J 30, 1733–1740, 2016.10.1096/fj.15-28093326718889
  110. Senese R, Cioffi F, de Lange P, Goglia F, Lanni A. Thyroid: biological actions of ‘nonclassical’ thyroid hormones. J Endocrinol 221, R1–R12, 2014.10.1530/JOE-13-057324464019
  111. Serrano M, Moreno M, Ortega FJ, Xifra G, Ricart W, Moreno-Navarrete JM, Fernandez-Real JM. Adipose tissue μ-crystallin is a thyroid hormone-binding protein associated with systemic insulin sensitivity. J Clin Endocrinol Metab 99, E2259–E2268, 2014.10.1210/jc.2014-132725057873
  112. Silva JE. Thyroid hormone and the energetic cost of keeping body temperature. Biosci Rep 25, 129–148, 2005.10.1007/s10540-005-2882-916283550
  113. Sivagnanasundaram S, Crossett B, Dedova I, Cordwell S, Matsumoto I. Abnormal pathways in the genu of the corpus callosum in schizophrenia pathogenesis: a proteome study. Proteomics Clin Appl 1, 1291–1305, 2007.10.1002/prca.20070023021136626
  114. Smith CM, Hayamizu TF, Finger JH, Bello SM, McCright IJ, Xu J, Baldarelli RM, Beal JS, Campbell J, Corbani LE, Frost PJ, Lewis JR, Giannatto SC, Miers D, Shaw DR, Kadin JA, Richardson JE, Smith CL, Ringwald M. The mouse Gene Expression Database (GXD): 2019 update. Nucleic Acids Res 47, D774-D779, 2019.10.1093/nar/gky922632405430335138
  115. Snyder PJ, Utiger RD. Response to thyrotropin releasing hormone (TRH) in normal man. J Clin Endocrinol Metab 34, 380–385, 1972.10.1210/jcem-34-2-380
  116. Sotelo-Rivera I, Cote-Velez A, Uribe RM, Charli JL, Joseph-Bravo P. Glucocorticoids curtail stimuli-induced CREB phosphorylation in TRH neurons through interaction of the glucocorticoid receptor with the catalytic subunit of protein kinase A. Endocrine 55, 861–871, 2017.10.1007/s12020-016-1223-z
  117. Sterling K, Campbell GA, Brenner MA. Purification of the mitochondrial triiodothyronine (T3) receptor from rat liver. Acta Endocrinol (Copenh) 105, 391–397, 1984.10.1530/acta.0.1050391
  118. Suzuki S, Suzuki N, Mori J, Oshima A, Usami S, Hashizume K. micro-Crystallin as an intracellular 3,5,3’-triiodothyronine holder in vivo. Mol Endocrinol 21, 885–894, 2007.10.1210/me.2006-0403
  119. Tagami T, Yamamoto H, Moriyama K, Sawai K, Usui T, Shimatsu A, Naruse M. Identification of a novel human thyroid hormone receptor beta isoform as a transcriptional modulator. Biochem Biophys Res Commun 396, 983–988, 2010.10.1016/j.bbrc.2010.05.038
  120. Tata JR. A cellular thyroxine-binding protein fraction. Biochim Biophys Acta 28, 91–94, 1958.10.1016/0006-3002(58)90432-3
  121. Tawil R, van der Maarel SM, Tapscott SJ. Facioscapulohumeral dystrophy: the path to consensus on pathophysiology. Skelet Muscle 4, 12, 2014.10.1186/2044-5040-4-12406006824940479
  122. Tennessen JA, Bigham AW, O’Connor TD, Fu W, Kenny EE, Gravel S, McGee S, Do R, Liu X, Jun G, Kang HM, Jordan D, Leal SM, Gabriel S, Rieder MJ, Abecasis G, Altshuler D, Nickerson DA, Boerwinkle E, Sunyaev S, Bustamante CD, Bamshad MJ, Akey JM; Broad GO; Seattle GO; NHLBI Exome Sequencing Project. Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science 337, 64–69, 2012.10.1126/science.1219240370854422604720
  123. Thul PJ, Akesson L, Wiking M, Mahdessian D, Geladaki A, Ait Blal H, Alm T, Asplund A, Bjork L, Breckels LM, Backstrom A, Danielsson F, Fagerberg L, Fall J, Gatto L, Gnann C, Hober S, Hjelmare M, Johansson F, Lee S, Lindskog C, Mulder J, Mulvey CM, Nilsson P, Oksvold P, Rockberg J, Schutten R, Schwenk JM, Sivertsson A, Sjostedt E, Skogs M, Stadler C, Sullivan DP, Tegel H, Winsnes C, Zhang C, Zwahlen M, Mardinoglu A, Ponten F, von Feilitzen K, Lilley KS, Uhlen M, Lundberg E. A subcellular map of the human proteome. Science 356, eaal3321, 2017.10.1126/science.aal332128495876
  124. Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson A, Kampf C, Sjostedt E, Asplund A, Olsson I, Edlund K, Lundberg E, Navani S, Szigyarto CA, Odeberg J, Djureinovic D, Takanen JO, Hober S, Alm T, Edqvist PH, Berling H, Tegel H, Mulder J, Rockberg J, Nilsson P, Schwenk JM, Hamsten M, von Feilitzen K, Forsberg M, Persson L, Johansson F, Zwahlen M, von Heijne G, Nielsen J, Ponten F. Proteomics. Tissue-based map of the human proteome. Science 347, 1260419, 2015.10.1126/science.126041925613900
  125. Vanderplanck C, Ansseau E, Charron S, Stricwant N, Tassin A, Laoudj-Chenivesse D, Wilton SD, Coppee F, Belayew A. The FSHD atrophic myotube phenotype is caused by DUX4 expression. PLoS One 6, e26820, 2011.10.1371/journal.pone.0026820320390522053214
  126. Velasco LF, Togashi M, Walfish PG, Pessanha RP, Moura FN, Barra GB, Nguyen P, Rebong R, Yuan C, Simeoni LA, Ribeiro RC, Baxter JD, Webb P, Neves FA. Thyroid hormone response element organization dictates the composition of active receptor. J Biol Chem 282, 12458–12466, 2007.10.1074/jbc.M61070020017311926
  127. Visser WE, Wong WS, van Mullem AA, Friesema EC, Geyer J, Visser TJ. Study of the transport of thyroid hormone by transporters of the SLC10 family. Mol Cell Endocrinol 315, 138–145, 2010.10.1016/j.mce.2009.08.00319682536
  128. Visser WE, Friesema EC, Visser TJ. Minireview: thyroid hormone transporters: the knowns and the unknowns. Mol Endocrinol 25, 1–14, 2011.10.1210/me.2010-0095541730220660303
  129. Walker DM, Zhao X, Ramakrishnan A, Cates HM, Cunningham AM, Pena CJ, Bagot RC, Issler O, Van der Zee Y, Lipschultz AP, Godino A, Browne CJ, Hodes GE, Parise EM, Torres-Berrio A, Kennedy PJ, Shen L, Zhang B, Nestler EJ. Adolescent social isolation reprograms the medial amygdala: transcriptome and sex differences in reward. bioRxiv, 955187, 2020.10.1101/2020.02.18.955187
  130. Wang M, Li Q, Deng A, Zhu X, Yang J. Identification of a novel mutation in CRYM in a Chinese family with hearing loss using whole-exome sequencing. Exp Ther Med 20, 1447–1454, 2020.10.3892/etm.2020.8890738829032742378
  131. Watanabe Y, Weiss RE. Thyroid hormone action. In: Encyclopedia of Endocrine Diseases, pp. 452–462, Elsevier, 2018.10.1016/B978-0-12-801238-3.96024-0
  132. Weinberger C, Thompson CC, Ong ES, Lebo R, Gruol DJ, Evans RM. The c-erb-A gene encodes a thyroid hormone receptor. Nature 324, 641–646, 1986.10.1038/324641a02879243
  133. Williams GR. Cloning and characterization of two novel thyroid hormone receptor beta isoforms. Mol Cell Biol 20, 8329–8342, 2000.10.1128/MCB.20.22.8329-8342.200010214011046130
  134. Williams GR, Bassett JH. Deiodinases: the balance of thyroid hormone: local control of thyroid hormone action: role of type 2 deiodinase. J Endocrinol 209, 261–272, 2011.10.1530/JOE-10-044821292729
  135. Wistow G, Kim H. Lens protein expression in mammals: taxon-specificity and the recruitment of crystallins. J Mol Evol 32, 262–269, 1991.10.1007/BF02342749
  136. Yarbrough GG. On the neuropharmacology of thyrotropin releasing hormone (TRH). Prog Neurobiol 12, 291–312, 1979.10.1016/0301-0082(79)90012-1
  137. Zimmermann RC, Krahn LE, Klee GG, Ditkoff EC, Ory SJ, Sauer MV. Prolonged inhibition of presynaptic catecholamine synthesis with alpha-methyl-para-tyrosine attenuates the circadian rhythm of human TSH secretion. J Soc Gynecol Investig 8, 174–178, 2001.10.1177/107155760100800309
DOI: https://doi.org/10.2478/enr-2021-0011 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668
Language: English
Page range: 89 - 102
Published on: May 21, 2021
Published by: Slovak Academy of Sciences, Mathematical Institute
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2021 Christian J. Kinney, Robert J. Bloch, published by Slovak Academy of Sciences, Mathematical Institute
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.